dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
LEOPARD: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema (clinicaltrials.gov) - Aug 12, 2024 - P2 | N=24 | Recruiting | Sponsor: Quan Dong Nguyen | Trial completion date: Dec 2024 ➔ Apr 2025 | Trial primary completion date: Oct 2024 ➔ Jan 2025 
Trial completion date • Trial primary completion date • Macular Edema • Ocular Inflammation • Ophthalmology • Uveitis
http://clinicaltrials.gov/ct2/show/NCT05608837
 
Aug 12, 2024
 
Prev Next